3 Reasons Nvidia Can Hit $300 per Share Before 2026 Is Over

Nvidia is discussed as a potential ~$300/share story, implying nearly a 50% rally from about $210 by end-2026. The article cites the Rubin upgrade cycle (inference at ~1/10 cost and training at ~1/4 cost vs Blackwell), and expects AI hyperscaler data-center capex to rise to >$1T next year from ~$650B in 2026 (about +54%). It also argues the stock is undervalued, trading at ~16x next year’s earnings versus 24x this year’s, and that Wall Street’s ~41% next-year revenue growth estimate understates the capex-driven demand outlook.

Analysis

Rubin looks less like a simple product refresh and more like a demand amplifier: if the cost per inference drops that sharply, customers will not buy fewer chips, they will try to justify more workloads. That favors NVDA in the near term because pricing power should improve before competition can respond, but it also raises the odds of tighter allocation at the package/foundry layer, which should keep TSM and advanced packaging vendors structurally busy.

The more interesting second-order effect is on hyperscaler economics. Faster cost declines can pull forward AI adoption, but they also invite budget discipline later: if management teams cannot show revenue monetization matching the capex curve, spending growth can decelerate hard after an initial buildout. That means the market may be over-pricing the 2027 spend narrative while under-pricing a 2H26 digestion phase if order visibility weakens or Blackwell-to-Rubin transition delays customer purchases.

Contrarian view: the consensus treats higher hyperscaler capex as a straight-line positive for NVDA, but efficiency gains can become deflationary for hardware ASPs and compress future multiples if unit volume growth matures. The thesis is falsified if 2026-27 capex commentary rolls over, NVDA gross margin surprises lower on mix/discounting, or Rubin timing slips enough to create a gap where customers pause orders awaiting the next platform.

Key Decisions for Investors

• Long NVDA on pullbacks over the next 1-2 months; use 12-month horizon. Risk/reward is attractive if 2027 capex confirmation lands, but trim if forward EPS growth slips below the low-30% range or the forward multiple compresses materially below ~20x.
• Pair trade: long NVDA / short AMD. This expresses platform share and pricing-power divergence without taking a broad AI beta bet. Fails if AMD closes the software/ecosystem gap or if NVDA lead times normalize faster than expected.
• Add TSM as a second-order beneficiary only on evidence of sustained advanced packaging demand; this is a 6-18 month trade, not a headline trade. Upside comes from manufacturing intensity, not the NVDA narrative itself.
• Set an alert for hyperscaler capex commentary in the next earnings cycle: if 2027 budgets come in below current street expectations, reduce NVDA exposure into strength; if capex is confirmed and guideposts tighten upward, the stock can re-rate further without needing a new catalyst.